ELAVL2 is located on chr9p21, and along with chr10 loss, chr9p deletion has been considered one of the most frequent genomic alterations in GBM, implying the presence of potential tumor suppressors on these deleted chromosomal segments40,41. The gene discussed is ELAVL2; the disease is neoplasm.